Avanos Medical (AVNS) EBITDA Margin (2013 - 2026)
Avanos Medical recorded quarterly EBITDA Margin of 4.88% in Q1 2026, up 253.46% quarter-over-quarter from 1.38% in Q4 2025, and down 126.0% year-over-year from 18.79% in Q1 2025.
Avanos Medical's EBITDA Margin history runs 14 years deep, the most recent figure standing at 4.88% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 126.0% year-over-year to 4.88%; the TTM figure through Mar 2026 stood at 8.8% (up 4777.0% YoY), while the FY2025 annual figure was 8.78%, up 4882.0% from the prior year.
- EBITDA Margin came in at 4.88% for Q1 2026 at Avanos Medical, up from 1.38% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 9.14% in Q4 2022 to a low of 233.02% in Q4 2024.
- A 5-year average of 13.0% and a median of 3.67% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 23948 bps in 2024 and surged 23440 bps in 2025, its largest moves.
- Avanos Medical's EBITDA Margin stood at 9.14% in 2022, then declined by 29 bps to 6.46% in 2023, then slumped by 3706 bps to 233.02% in 2024, then jumped by 101 bps to 1.38% in 2025, then surged by 253 bps to 4.88% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 4.88%, 1.38%, and 0.06% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 4.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.88% |
| Dec 31, 2025 | 1.38% |
| Sep 30, 2025 | 0.06% |
| Jun 30, 2025 | -42.57% |
| Mar 31, 2025 | 6.15% |
| Dec 31, 2024 | -233.02% |
| Sep 30, 2024 | 7.04% |
| Jun 30, 2024 | 3.67% |
| Mar 31, 2024 | 2.41% |
| Dec 31, 2023 | 6.46% |
| Sep 30, 2023 | 0.70% |
| Jun 30, 2023 | -1.24% |
| Mar 31, 2023 | -3.83% |
| Dec 31, 2022 | 9.14% |
| Sep 30, 2022 | 7.43% |
| Jun 30, 2022 | 5.91% |
| Mar 31, 2022 | 4.36% |
| Dec 31, 2021 | -62.57% |
| Sep 30, 2021 | 1.85% |
| Jun 30, 2021 | -3.92% |
| Mar 31, 2021 | -6.86% |
| Dec 31, 2020 | -25.51% |
| Sep 30, 2020 | -0.05% |
| Jun 30, 2020 | -1.10% |
| Mar 31, 2020 | 0.33% |
| Dec 31, 2019 | -1.69% |
| Sep 30, 2019 | -10.56% |
| Jun 30, 2019 | -5.69% |
| Mar 31, 2019 | -14.98% |
| Dec 31, 2018 | -4.89% |
| Sep 30, 2018 | 4.24% |
| Jun 30, 2018 | 5.47% |
| Mar 31, 2018 | -4.48% |
| Dec 31, 2017 | -1.80% |
| Sep 30, 2017 | -6.91% |
| Jun 30, 2017 | -8.12% |
| Mar 31, 2017 | -12.08% |
| Dec 31, 2016 | 29.01% |
| Sep 30, 2016 | 5.26% |
| Jun 30, 2016 | 4.40% |
| Mar 31, 2016 | 8.60% |
| Dec 31, 2015 | -39.53% |
| Sep 30, 2015 | -118.41% |
| Jun 30, 2015 | 5.68% |
| Mar 31, 2015 | 10.38% |
| Dec 31, 2014 | 5.46% |
| Sep 30, 2014 | 3.21% |
| Jun 30, 2014 | -1.09% |
| Mar 31, 2014 | 15.02% |
| Dec 31, 2013 | 13.35% |
| Sep 30, 2013 | 16.76% |